STOCK TITAN

[6-K] SciSparc Ltd. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

SciSparc announced that shareholders approved all proposals at their adjourned annual general meeting held on June 26, 2025. The meeting resulted in the approval of two significant documents:

  • A new amended and restated articles of association
  • An updated compensation policy for executive officers and directors

These approvals were obtained with the requisite majority in accordance with Israeli Companies Law and the company's existing articles of association. The proposals were previously detailed in a proxy statement furnished to the SEC on May 21, 2025.

The Form 6-K filing will be incorporated into multiple company registration statements, including several Form F-3s (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) and Form S-8s (File Nos. 333-278437, 333-225773, 333-286791). The document was signed by Oz Adler, Chief Executive Officer.

SciSparc ha annunciato che gli azionisti hanno approvato tutte le proposte durante l'assemblea generale annuale rinviata tenutasi il 26 giugno 2025. L'incontro ha portato all'approvazione di due documenti importanti:

  • Un nuovo statuto sociale modificato e aggiornato
  • Una politica di compensazione aggiornata per i dirigenti e i membri del consiglio di amministrazione

Queste approvazioni sono state ottenute con la maggioranza richiesta in conformità alla legge israeliana sulle società e allo statuto vigente della società. Le proposte erano state precedentemente illustrate in una dichiarazione per delega presentata alla SEC il 21 maggio 2025.

La comunicazione Form 6-K sarà inclusa in diverse dichiarazioni di registrazione della società, comprese varie Form F-3 (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) e Form S-8 (File Nos. 333-278437, 333-225773, 333-286791). Il documento è stato firmato da Oz Adler, Amministratore Delegato.

SciSparc anunció que los accionistas aprobaron todas las propuestas en su junta general anual aplazada celebrada el 26 de junio de 2025. La reunión resultó en la aprobación de dos documentos importantes:

  • Un nuevo estatuto social enmendado y reformulado
  • Una política de compensación actualizada para los altos ejecutivos y directores

Estas aprobaciones se obtuvieron con la mayoría requerida conforme a la Ley de Sociedades de Israel y los estatutos vigentes de la empresa. Las propuestas se detallaron previamente en una declaración por poder presentada a la SEC el 21 de mayo de 2025.

El formulario 6-K se incorporará en múltiples declaraciones de registro de la empresa, incluyendo varios Formularios F-3 (Números de archivo 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) y Formularios S-8 (Números de archivo 333-278437, 333-225773, 333-286791). El documento fue firmado por Oz Adler, Director Ejecutivo.

SciSparc는 2025년 6월 26일에 개최된 연기된 정기 주주총회에서 주주들이 모든 안건을 승인했다고 발표했습니다. 회의 결과 두 가지 중요한 문서가 승인되었습니다:

  • 새롭게 수정 및 재작성된 정관
  • 임원 및 이사에 대한 최신 보상 정책

이러한 승인은 이스라엘 회사법과 회사의 기존 정관에 따라 필요한 과반수 찬성으로 이루어졌습니다. 제안 내용은 2025년 5월 21일에 SEC에 제출된 위임장 설명서에 사전에 상세히 명시되었습니다.

Form 6-K 제출서는 여러 회사 등록 서류에 포함될 예정이며, 여기에는 여러 Form F-3(파일 번호 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) 및 Form S-8(파일 번호 333-278437, 333-225773, 333-286791)이 포함됩니다. 해당 문서는 최고경영자인 Oz Adler가 서명했습니다.

SciSparc a annoncé que les actionnaires ont approuvé toutes les propositions lors de leur assemblée générale annuelle ajournée tenue le 26 juin 2025. La réunion a abouti à l'approbation de deux documents importants :

  • Un nouveau règlement intérieur modifié et reformulé
  • Une politique de rémunération mise à jour pour les dirigeants et administrateurs

Ces approbations ont été obtenues avec la majorité requise conformément à la loi israélienne sur les sociétés et aux statuts existants de la société. Les propositions avaient été détaillées précédemment dans une déclaration de procuration fournie à la SEC le 21 mai 2025.

Le dépôt du formulaire 6-K sera intégré dans plusieurs déclarations d'enregistrement de la société, y compris plusieurs formulaires F-3 (numéros de dossier 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) et formulaires S-8 (numéros de dossier 333-278437, 333-225773, 333-286791). Le document a été signé par Oz Adler, Directeur Général.

SciSparc gab bekannt, dass die Aktionäre bei ihrer vertagten jährlichen Hauptversammlung am 26. Juni 2025 alle Vorschläge genehmigt haben. Die Versammlung führte zur Zustimmung von zwei bedeutenden Dokumenten:

  • Eine neue geänderte und neu gefasste Satzung
  • Eine aktualisierte Vergütungspolitik für Führungskräfte und Direktoren

Diese Genehmigungen wurden mit der erforderlichen Mehrheit gemäß dem israelischen Gesellschaftsrecht und der bestehenden Satzung des Unternehmens erzielt. Die Vorschläge wurden zuvor in einer Vollmachtsmitteilung dargelegt, die der SEC am 21. Mai 2025 vorgelegt wurde.

Die Form 6-K Einreichung wird in mehrere Unternehmensregistrierungserklärungen aufgenommen, darunter mehrere Formulare F-3 (Aktenzeichen 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) und Formulare S-8 (Aktenzeichen 333-278437, 333-225773, 333-286791). Das Dokument wurde von Oz Adler, Chief Executive Officer, unterzeichnet.

Positive
  • None.
Negative
  • None.

SciSparc ha annunciato che gli azionisti hanno approvato tutte le proposte durante l'assemblea generale annuale rinviata tenutasi il 26 giugno 2025. L'incontro ha portato all'approvazione di due documenti importanti:

  • Un nuovo statuto sociale modificato e aggiornato
  • Una politica di compensazione aggiornata per i dirigenti e i membri del consiglio di amministrazione

Queste approvazioni sono state ottenute con la maggioranza richiesta in conformità alla legge israeliana sulle società e allo statuto vigente della società. Le proposte erano state precedentemente illustrate in una dichiarazione per delega presentata alla SEC il 21 maggio 2025.

La comunicazione Form 6-K sarà inclusa in diverse dichiarazioni di registrazione della società, comprese varie Form F-3 (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) e Form S-8 (File Nos. 333-278437, 333-225773, 333-286791). Il documento è stato firmato da Oz Adler, Amministratore Delegato.

SciSparc anunció que los accionistas aprobaron todas las propuestas en su junta general anual aplazada celebrada el 26 de junio de 2025. La reunión resultó en la aprobación de dos documentos importantes:

  • Un nuevo estatuto social enmendado y reformulado
  • Una política de compensación actualizada para los altos ejecutivos y directores

Estas aprobaciones se obtuvieron con la mayoría requerida conforme a la Ley de Sociedades de Israel y los estatutos vigentes de la empresa. Las propuestas se detallaron previamente en una declaración por poder presentada a la SEC el 21 de mayo de 2025.

El formulario 6-K se incorporará en múltiples declaraciones de registro de la empresa, incluyendo varios Formularios F-3 (Números de archivo 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) y Formularios S-8 (Números de archivo 333-278437, 333-225773, 333-286791). El documento fue firmado por Oz Adler, Director Ejecutivo.

SciSparc는 2025년 6월 26일에 개최된 연기된 정기 주주총회에서 주주들이 모든 안건을 승인했다고 발표했습니다. 회의 결과 두 가지 중요한 문서가 승인되었습니다:

  • 새롭게 수정 및 재작성된 정관
  • 임원 및 이사에 대한 최신 보상 정책

이러한 승인은 이스라엘 회사법과 회사의 기존 정관에 따라 필요한 과반수 찬성으로 이루어졌습니다. 제안 내용은 2025년 5월 21일에 SEC에 제출된 위임장 설명서에 사전에 상세히 명시되었습니다.

Form 6-K 제출서는 여러 회사 등록 서류에 포함될 예정이며, 여기에는 여러 Form F-3(파일 번호 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) 및 Form S-8(파일 번호 333-278437, 333-225773, 333-286791)이 포함됩니다. 해당 문서는 최고경영자인 Oz Adler가 서명했습니다.

SciSparc a annoncé que les actionnaires ont approuvé toutes les propositions lors de leur assemblée générale annuelle ajournée tenue le 26 juin 2025. La réunion a abouti à l'approbation de deux documents importants :

  • Un nouveau règlement intérieur modifié et reformulé
  • Une politique de rémunération mise à jour pour les dirigeants et administrateurs

Ces approbations ont été obtenues avec la majorité requise conformément à la loi israélienne sur les sociétés et aux statuts existants de la société. Les propositions avaient été détaillées précédemment dans une déclaration de procuration fournie à la SEC le 21 mai 2025.

Le dépôt du formulaire 6-K sera intégré dans plusieurs déclarations d'enregistrement de la société, y compris plusieurs formulaires F-3 (numéros de dossier 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) et formulaires S-8 (numéros de dossier 333-278437, 333-225773, 333-286791). Le document a été signé par Oz Adler, Directeur Général.

SciSparc gab bekannt, dass die Aktionäre bei ihrer vertagten jährlichen Hauptversammlung am 26. Juni 2025 alle Vorschläge genehmigt haben. Die Versammlung führte zur Zustimmung von zwei bedeutenden Dokumenten:

  • Eine neue geänderte und neu gefasste Satzung
  • Eine aktualisierte Vergütungspolitik für Führungskräfte und Direktoren

Diese Genehmigungen wurden mit der erforderlichen Mehrheit gemäß dem israelischen Gesellschaftsrecht und der bestehenden Satzung des Unternehmens erzielt. Die Vorschläge wurden zuvor in einer Vollmachtsmitteilung dargelegt, die der SEC am 21. Mai 2025 vorgelegt wurde.

Die Form 6-K Einreichung wird in mehrere Unternehmensregistrierungserklärungen aufgenommen, darunter mehrere Formulare F-3 (Aktenzeichen 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408) und Formulare S-8 (Aktenzeichen 333-278437, 333-225773, 333-286791). Das Dokument wurde von Oz Adler, Chief Executive Officer, unterzeichnet.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of June 2025 (Report No. 4)

 

Commission file number: 001- 38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F Form 40-F 

 

 

 

 

CONTENTS

 

SciSparc Ltd. (the “Company”) hereby announces that the shareholders of the Company approved all of the proposals brought before the adjourned annual general meeting of shareholders held on June 26, 2025 (the “Meeting”), by the respective requisite majority in accordance with the Israeli Companies Law, 5759-1999, and the Company’s amended and restated articles of association, as described in the Proxy Statement which was attached as Exhibit 99.1 to the Company’s Report of Foreign Private Issuer on Form 6-K, furnished to the Securities and Exchange Commission (the “SEC”) on May 21, 2025, and sent to shareholders in connection with the Meeting.

 

A copy of the Company’s amended and restated articles of association, approved by shareholders at the Meeting, is attached hereto as Exhibit 99.1.

 

A copy of the Company’s compensation policy, approved by shareholders at the Meeting, is attached hereto as Exhibit 99.2.

 

This Report of Foreign Private Issuer on Form 6-Kis incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-286099333-275305333-269839333-266047333-248670 and 333-255408) and on Form S-8 (File Nos. 333-278437333-225773 and 333-286791) filed with the SEC to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

- 1 -

 

Exhibits No.    
99.1   Amended and Restated Articles of Association.
     
99.2   Compensation Policy for Executive Officers and Directors.

 

- 2 -

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SciSparc Ltd.
   
Date: June 26, 2025 By: /s/ Oz Adler
    Name: Oz Adler
Title: Chief Executive Officer

 

 

- 3 -

 

FAQ

What was approved at SPRC's annual general meeting on June 26, 2025?

At SPRC's annual general meeting on June 26, 2025, shareholders approved all proposals presented, including a new amended and restated articles of association and a new compensation policy for executive officers and directors. The proposals were approved by the required majority in accordance with Israeli Companies Law.

When did SPRC file its latest Form 6-K and what was it about?

SPRC filed a Form 6-K on June 28, 2025 (Report No. 4) to announce the results of their annual general meeting held on June 26, 2025. The filing included information about shareholder approvals and new corporate documents.

Who is the current CEO of SPRC as of June 2025?

According to the Form 6-K filing's signature page, Oz Adler is serving as the Chief Executive Officer of SciSparc Ltd. as of June 2025.

What SEC registration statements does SPRC's June 2025 6-K filing affect?

The 6-K filing is incorporated into SPRC's Form F-3 registration statements (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, and 333-255408) and Form S-8 registration statements (File Nos. 333-278437, 333-225773, and 333-286791).

Where is SPRC's principal executive office located?

SPRC's principal executive office is located at 20 Raul Wallenberg Street, Tower A, Tel Aviv 6971916, Israel.
Scisparc

NASDAQ:SPRC

SPRC Rankings

SPRC Latest News

SPRC Latest SEC Filings

SPRC Stock Data

3.37M
11.23M
0%
1.21%
0.62%
Biotechnology
Healthcare
Link
Israel
Tel Aviv